FDA Adverse Event Injury Summary report: N

AFX SYSTEM

MDR report key: 3855074 · Received June 9, 2014

Report

Report Number
2031527-2014-00173
Event Type
Injury
Date Received
June 9, 2014
Date of Event
May 9, 2014
Report Date
May 22, 2014
Manufacturer
ENDOLOGIX, INC.
Product Code
MIH
PMA / PMN Number
P040002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ENDOLOGIX CONTINUES TO INVESTIGATE THE REPORTED EVENT. ENDOLOGIX WILL SUBMIT A SUPPLEMENTAL REPORT IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE. DEVICE REMAINS IMPLANTED IN PATIENT.

Additional Manufacturer Narrative · 1

THE DEVICE REMAINS IMPLANTED IN THE PATIENT, HENCE DEVICE EVALUATION COULD NOT BE PERFORMED. MEDICAL RECORDS OR IMAGES WERE NOT PROVIDED FOR CLINICAL ASSESSMENT; THEREFORE, A THOROUGH CLINICAL INVESTIGATION OF THE MEDICAL RECORDS WAS NOT POSSIBLE AND A CAUSE COULD NOT BE DETERMINED. ENDOLEAKS ARE A KNOWN INHERENT RISK OF THE PROCEDURE. A MANUFACTURING RECORD REVIEW WAS PERFORMED AND THE LOT MET ALL RELEASE CRITERIA WITH NO ISSUES OR DEVIATIONS THAT WOULD EXPLAIN THE REPORTED EVENT. THE LOT USAGE HISTORY SHOWED THAT NO OTHER UNITS FROM THE SAME LOT HAVE BEEN INVOLVED IN ANY SIMILAR EVENT. THE PRODUCT LABELING WAS REVIEWED AND CONFIRMED THAT THE REPORTED EVENT IS ADEQUATELY CAPTURED IN THE EXISTING LABELING. CORRECTED DATA: COMMON DEVICE NAME.

Description of Event or Problem · 1

IT WAS REPORTED THAT APPROXIMATELY 15 DAYS POST IMPLANT OF A BIFURCATED DEVICE, TWO INFRARENAL AND ONE SUPRARENAL AORTIC EXTENSIONS, A FOLLOW-UP COMPUTED TOMOGRAPHY SCAN REVEALED A PROXIMAL ENDOLEAK. THE PHYSICIAN ELECTED TO IMPLANT AN ADDITIONAL INFRARENAL AORTIC EXTENSION, WHICH RESOLVED THE ENDOLEAK. IT WAS REPORTED THAT THE PATIENT TOLERATED THE PROCEDURE WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
335629 AFX SYSTEM SUPRARENAL PROXIMAL EXTENSION STENT GRAFT, PRODUCT CODE:MIH MIH ENDOLOGIX, INC. A34-34/C80-O20V 1203084-019

Patients

Seq Age Sex Outcome Treatment
1 68 YR Required Intervention